Codexis Inc (CDXS) - Financial and Strategic SWOT Analysis Review

Date: May 23, 2017
Pages: 49
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C27740FC7E2EN
Leaflet:

Download PDF Leaflet

Codexis Inc (CDXS) - Financial and Strategic SWOT Analysis Review
Codexis Inc (CDXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs), Codex screening panels and kits, and enzyme platforms. It also offers a wide range of biocatalysis solutions ranging from screening and optimization to commercial supply of biocatalysts. Codexis discovers, identifies, optimizes and produces enzymes by using its technology platforms such as CodeEvolver, protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. The company serves specialist businesses, pharmaceutical, food manufacturing and chemical companies. Codexis is headquartered in Redwood City, California, the US.

Codexis Inc Key Recent Developments

May 09,2017: Codexis Reports Financial Results for the First Quarter of 2017
Mar 09,2017: Codexis Reports 2016 Fourth Quarter and Full Year Financial Results
Jan 06,2017: Codexis to Offer High-Performance Enzymes for Diagnostics Markets
Dec 01,2016: Codexis names new chairman
Nov 08,2016: Codexis Reports Financial Results for the Third Quarter of 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Codexis Inc - Key Facts
Codexis Inc - Key Employees
Codexis Inc - Key Employee Biographies
Codexis Inc - Major Products and Services
Codexis Inc - Pharmaceutical Pipeline Products Data
Codexis Inc, Pipeline Products by Therapy Area
Codexis Inc, Pipeline Products by Development Phase
Codexis Inc - History
Codexis Inc - Company Statement
Codexis Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Codexis Inc - Business Description
Codexis Inc - Corporate Strategy
Codexis Inc - SWOT Analysis
SWOT Analysis - Overview
Codexis Inc - Strengths
Codexis Inc - Weaknesses
Codexis Inc - Opportunities
Codexis Inc - Threats
Codexis Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Codexis Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 09, 2017: Codexis Reports Financial Results for the First Quarter of 2017
Mar 09, 2017: Codexis Reports 2016 Fourth Quarter and Full Year Financial Results
Jan 06, 2017: Codexis to Offer High-Performance Enzymes for Diagnostics Markets
Dec 01, 2016: Codexis names new chairman
Nov 08, 2016: Codexis Reports Financial Results for the Third Quarter of 2016
Oct 17, 2016: Michael Aldridge Joins Codexis as Senior Vice President, Corporate & Strategic Development
Aug 09, 2016: Codexis Reports Financial Results for the Second Quarter of 2016
Jul 28, 2016: Codexis Completes Obligations Under Research and Development Agreement with Leading Biopharmaceutical Company
May 09, 2016: Codexis Reports Financial Results for the First Quarter of 2016
Mar 03, 2016: Codexis Adds Life Sciences Industry Veteran David V. Smith to Its Board of Directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Codexis Inc, Key Facts
Codexis Inc, Key Employees
Codexis Inc, Key Employee Biographies
Codexis Inc, Major Products and Services
Codexis Inc, Number of Pipeline Products by Therapy Area
Codexis Inc, Number of Pipeline Products by Development Stage
Codexis Inc, History
Codexis Inc, Subsidiaries
Codexis Inc, Key Competitors
Codexis Inc, Ratios based on current share price
Codexis Inc, Annual Ratios
Codexis Inc, Annual Ratios (Cont.1)
Codexis Inc, Interim Ratios
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Codexis Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Codexis Inc, Pipeline Products by Therapy Area
Codexis Inc, Pipeline Products by Development Phase
Codexis Inc, Performance Chart (2012 - 2016)
Codexis Inc, Ratio Charts
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Codexis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Takasago International Corporation (U.S.A.)
Solvias Inc
Royal DSM NV
Novozymes A/S
evocatal GmbH
c-LEcta GmbH
Cambrex Corp
Biotechnology Research And Information Network AG
Almac Group Ltd
Skip to top


Ask Your Question

Codexis Inc (CDXS) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: